Furthermore, we analyzed details regarding the treatment of BCR::ABL1-negative MPN at the time of secondary CML diagnosis (Supplemental Fig. 2). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.